ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $727,000 | +19.0% | 61,803 | +38.1% | 0.01% | -35.0% |
| Q1 2019 | $611,000 | +259.4% | 44,741 | +169.6% | 0.02% | +150.0% |
| Q4 2018 | $170,000 | -50.3% | 16,597 | -23.3% | 0.01% | -52.9% |
| Q2 2018 | $342,000 | -2.6% | 21,639 | -21.6% | 0.02% | -19.0% |
| Q1 2018 | $351,000 | +26.7% | 27,614 | +14.1% | 0.02% | +40.0% |
| Q4 2017 | $277,000 | -3.1% | 24,209 | +3.6% | 0.02% | -6.2% |
| Q3 2017 | $286,000 | +652.6% | 23,373 | +611.7% | 0.02% | +700.0% |
| Q2 2017 | $38,000 | -54.2% | 3,284 | -18.2% | 0.00% | -71.4% |
| Q4 2016 | $83,000 | +84.4% | 4,013 | +190.8% | 0.01% | +133.3% |
| Q3 2016 | $45,000 | +28.6% | 1,380 | -1.4% | 0.00% | +50.0% |
| Q2 2016 | $35,000 | +52.2% | 1,400 | +47.1% | 0.00% | +100.0% |
| Q1 2016 | $23,000 | -67.6% | 952 | -55.6% | 0.00% | -75.0% |
| Q4 2015 | $71,000 | -65.4% | 2,142 | -65.8% | 0.00% | -60.0% |
| Q3 2015 | $205,000 | -69.0% | 6,269 | -49.8% | 0.01% | -68.8% |
| Q2 2015 | $662,000 | +321.7% | 12,495 | +130.4% | 0.03% | +300.0% |
| Q1 2015 | $157,000 | +946.7% | 5,424 | +971.9% | 0.01% | +700.0% |
| Q4 2014 | $15,000 | – | 506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |